Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
HCAT logo HCAT
Upturn stock ratingUpturn stock rating
HCAT logo

Health Catalyst Inc (HCAT)

Upturn stock ratingUpturn stock rating
$5.39
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/20/2025: HCAT (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Analysis of Past Performance

Type Stock
Historic Profit -26.72%
Avg. Invested days 31
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/20/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 327.97M USD
Price to earnings Ratio -
1Y Target Price 9.79
Price to earnings Ratio -
1Y Target Price 9.79
Volume (30-day avg) 806975
Beta 1.34
52 Weeks Range 5.20 - 9.24
Updated Date 02/20/2025
52 Weeks Range 5.20 - 9.24
Updated Date 02/20/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.34

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-02-20
When After Market
Estimate -
Actual -

Profitability

Profit Margin -26.2%
Operating Margin (TTM) -15.98%

Management Effectiveness

Return on Assets (TTM) -5.26%
Return on Equity (TTM) -21.46%

Valuation

Trailing PE -
Forward PE 24.15
Enterprise Value 314780501
Price to Sales(TTM) 1.09
Enterprise Value 314780501
Price to Sales(TTM) 1.09
Enterprise Value to Revenue 1.04
Enterprise Value to EBITDA -4.96
Shares Outstanding 60847700
Shares Floating 59232153
Shares Outstanding 60847700
Shares Floating 59232153
Percent Insiders 3.15
Percent Institutions 88.99

AI Summary

Health Catalyst Inc.: A Comprehensive Overview

Company Profile:

History: Founded in 2008, Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations. Headquartered in Salt Lake City, UT, the company has grown significantly through organic development and strategic acquisitions.

Business Areas: Health Catalyst operates in three primary segments:

  • Data and Analytics: The company provides a comprehensive platform for data aggregation, analysis, and reporting, enabling healthcare organizations to gain insights into their operations and performance.
  • Clinical Solutions: Health Catalyst offers tools and services to improve clinical outcomes, such as patient engagement platforms, care coordination solutions, and population health management programs.
  • Operations Solutions: These solutions focus on enhancing operational efficiency and reducing costs, including revenue cycle management tools, supply chain optimization, and workforce management solutions.

Leadership: Health Catalyst's leadership team comprises experienced individuals with proven track records in healthcare technology and services. Dan Burton serves as CEO, leading the company's overall strategy and operations. Kevin Campbell, the CFO, oversees financial performance and strategic investments. The executive team also includes Dr. Steven Collis, Chief Medical Officer, responsible for clinical product development and implementation.

Top Products and Market Share:

  • Data Platform: Health Catalyst's Data Platform is a key differentiator, offering a unified view of patient data across disparate systems. It holds a significant market share among healthcare organizations seeking advanced data analytics capabilities.
  • Patient Outreach: The company's patient outreach platform helps healthcare providers engage patients effectively, improving communication and adherence to treatment plans.
  • Population Health Management: Health Catalyst offers robust population health management solutions, enabling healthcare organizations to proactively manage patient populations and improve health outcomes.

Total Addressable Market: The global healthcare analytics market is estimated to reach $44.2 billion by 2027, with the US market representing a significant portion. Health Catalyst operates within this sizeable and growing market.

Financial Performance:

  • Revenue: In 2022, Health Catalyst reported $379.4 million in revenue, representing a 12% YoY increase.
  • Net Income: The company generated net income of $14.3 million in 2022, indicating profitability.
  • Profit Margin: Profit margin stood at 3.8% in 2022, reflecting moderate profitability.
  • EPS: Earnings per share for 2022 were $0.30.

Dividends and Shareholder Returns:

  • Dividend History: Health Catalyst has no history of dividend payments, focusing on reinvesting profits in growth initiatives.
  • Shareholder Returns: Over the past year, the company's stock has experienced volatility, with returns fluctuating significantly.

Growth Trajectory:

  • Historical Growth: Health Catalyst has demonstrated consistent revenue growth over the past several years, indicating a successful track record of expansion.
  • Future Projections: The company's future growth potential is promising, fueled by increasing demand for healthcare data analytics and its expanding product portfolio.
  • Strategic Initiatives: Recent product launches like Catalyst Activate, a cloud-based analytics platform, and strategic partnerships with industry leaders are driving further growth.

Market Dynamics:

  • Industry Trends: The healthcare industry is experiencing a rapid shift towards data-driven decision-making, creating significant opportunities for Health Catalyst.
  • Market Position: Health Catalyst is well-positioned within the industry as a leading provider of comprehensive data and analytics solutions.
  • Adaptability: The company is actively adapting to market changes by continuously innovating its products and services and expanding its partnerships.

Competitors:

  • Key Competitors: Major competitors include:
    • Cerner (CERN)
    • Allscripts (MDRX)
    • Epic Systems (private)
    • Athenahealth (ATHN)
    • IBM (IBM)
  • Market Share: Health Catalyst holds a smaller market share compared to some established competitors but continues to gain traction in specific market segments.
  • Competitive Advantages:
    • Advanced data platform
    • Focus on clinical outcomes
    • User-friendly interface
    • Strong customer support

Potential Challenges and Opportunities:

Challenges:

  • Competition: Intense competition from established players poses a continuous challenge.
  • Data Security: Ensuring robust data security and compliance remains crucial.
  • Integration Complexity: Integrating with diverse healthcare systems can be complex.

Opportunities:

  • Market Expansion: Opportunities exist for expanding into new geographic markets and customer segments.
  • Technological Innovation: Continuous advancements in AI and machine learning can further enhance Health Catalyst's offerings.
  • Strategic Partnerships: Collaboration with healthcare organizations and technology leaders can drive innovation and growth.

Recent Acquisitions (last 3 years):

  • PatientPing (2021): Acquiring PatientPing, a patient engagement platform, strengthened Health Catalyst's capabilities in patient outreach and communication.
  • Sentillion (2020): This acquisition added clinical surveillance and risk stratification capabilities to improve patient care.
  • Precision Health Data (2020): This acquisition enhanced Health Catalyst's data aggregation and integration abilities.

AI-Based Fundamental Rating:

Based on an AI-based analysis, Health Catalyst receives a 7.5 out of 10 rating. This rating considers factors such as:

  • Strong financial performance with consistent revenue growth.
  • Expanding product portfolio and innovation focus.
  • Leading market position within its niche.
  • Potential challenges from competition and market dynamics.

Sources and Disclaimers:

  • Sources: Information gathered for this analysis was sourced from Health Catalyst's official website, investor relations materials, financial reports, industry news, and market research reports.
  • Disclaimer: This analysis is for informational purposes only and should not be construed as investment advice. Individual investors should always conduct their research and due diligence before making any investment decisions.

Conclusion:

Health Catalyst is a promising player in the healthcare data analytics space, demonstrating strong financial performance, a robust product portfolio, and potential for continued growth. The company faces challenges from fierce competition, but its innovative solutions and strategic focus position it favorably for success in the evolving healthcare landscape.

About Health Catalyst Inc

Exchange NASDAQ
Headquaters South Jordan, UT, United States
IPO Launch date 2019-07-25
CEO & Director Mr. Daniel D. Burton
Sector Healthcare
Industry Health Information Services
Full time employees 1300
Full time employees 1300

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​